Saleem Zikria, Godman Brian, Cook Aislinn, Khan Muhammad Arslan, Campbell Stephen M, Seaton Ronald Andrew, Siachalinga Linda, Haseeb Abdul, Amir Afreenish, Kurdi Amanj, Mwita Julius C, Sefah Israel Abebrese, Opanga Sylvia A, Fadare Joseph O, Ogunleye Olayinka O, Meyer Johanna C, Massele Amos, Kibuule Dan, Kalungia Aubrey C, Shahwan Moyad, Nabayiga Hellen, Pichierri Giuseppe, Moore Catrin E
Department of Pharmacy Practice, Faculty of Pharmacy, Bahauddin Zakariya University, Multan 60800, Pakistan.
Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Antibiotics (Basel). 2022 Dec 15;11(12):1824. doi: 10.3390/antibiotics11121824.
There are serious concerns with rising antimicrobial resistance (AMR) across countries increasing morbidity, mortality and costs. These concerns have resulted in a plethora of initiatives globally and nationally including national action plans (NAPs) to reduce AMR. Africa is no exception, especially with the highest rates of AMR globally. Key activities in NAPs include gaining a greater understanding of current antimicrobial utilization patterns through point prevalence surveys (PPS) and subsequently instigating antimicrobial stewardship programs (ASPs). Consequently, there is a need to comprehensively document current utilization patterns among hospitals across Africa coupled with ASP studies. In total, 33 PPS studies ranging from single up to 18 hospitals were documented from a narrative review with typically over 50% of in-patients prescribed antimicrobials, up to 97.6% in Nigeria. The penicillins, ceftriaxone and metronidazole, were the most prescribed antibiotics. Appreciable extended prescribing of antibiotics up to 6 days or more post-operatively was seen across Africa to prevent surgical site infections. At least 19 ASPs have been instigated across Africa in recent years to improve future prescribing utilizing a range of prescribing indicators. The various findings resulted in a range of suggested activities that key stakeholders, including governments and healthcare professionals, should undertake in the short, medium and long term to improve future antimicrobial prescribing and reduce AMR across Africa.
各国对抗菌素耐药性(AMR)不断上升深感担忧,因为这会增加发病率、死亡率和成本。这些担忧促使全球和各国纷纷采取大量举措,包括制定国家行动计划(NAP)以降低抗菌素耐药性。非洲也不例外,尤其是其抗菌素耐药率全球最高。国家行动计划的关键活动包括通过现患率调查(PPS)更深入地了解当前抗菌药物使用模式,随后启动抗菌药物管理计划(ASP)。因此,有必要全面记录非洲各医院当前的使用模式,并开展抗菌药物管理计划研究。通过叙述性综述,共记录了33项现患率调查研究,涉及医院数量从1家到18家不等,通常超过50%的住院患者使用了抗菌药物,在尼日利亚这一比例高达97.6%。青霉素、头孢曲松和甲硝唑是最常使用的抗生素。在非洲各地,为预防手术部位感染,术后使用抗生素延长至6天或更长时间的情况很常见。近年来,非洲至少启动了19项抗菌药物管理计划,以利用一系列处方指标改善未来的处方行为。各项研究结果提出了一系列建议活动,包括政府和医疗保健专业人员在内的主要利益相关者应在短期、中期和长期内开展这些活动,以改善非洲未来的抗菌药物处方并降低抗菌素耐药性。